This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) slid 2.79% to $6.98 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.15% to 4,357.04 and the Dow Jones Industrial Average rising 1.43% to 34,326.46. Ocugen Inc. closed $11.79 below its 52-week high ($18.77), which the company achieved on February 8th.
The stock underperformed when compared to some of its competitors Friday, as Adverum Biotechnologies Inc. (ADVM) rose 0.46% to $2.18, Ocular Therapeutix Inc. (OCUL) rose 3.70% to $10.37, and Kodiak Sciences Inc. (KOD) rose 1.06% to $97.00. Trading volume (10.0 M) remained 2.1 million below its 50-day average volume of 12.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2021.
(END) Dow Jones Newswires
October 01, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.